Skip to main content
. 2023 May 16;109(7):1852–1862. doi: 10.1097/JS9.0000000000000437

Table 4.

Comparison of lymph node metastasis between EPNI positive and negative patients after operation.

Overall EPNI (-) EPNI (+) P
96 40 56
Positive LN (%)
 <=3 60 (62.5) 28 (70.0) 32 (57.1) 0.285
 >3 36 (37.5) 12 (30.0) 24 (42.9)
LN dissection (%)
 <=24 54 (56.2) 26 (65.0) 28 (50.0) 0.211
 >24 42 (43.8) 14 (35.0) 28 (50.0)
Type (%)
 I 32 (33.3) 11 (27.5) 21 (37.5) 0.545
 II 38 (39.6) 18 (45.0) 20 (35.7)
 III 26 (27.1) 11 (27.5) 15 (26.8)
PLX1 (%) 28 (56.0) 2 (14.3) 26 (72.2) 0.001
PLX2 (%) 30 (54.5) 4 (20.0) 26 (74.3) <0.001
EPNI (%) 47 (49.0) 6 (15.0) 41 (73.2) <0.001
No. 14.ab (%) 17 (17.7) 4 (10.0) 13 (23.2) 0.161
No. 14.cd (%) 11 (17.2) 1 (3.4) 10 (28.6) 0.020
No. 9 (%) 16 (27.6) 2 (9.1) 14 (38.9) 0.031
No. 8a (%) 39 (40.6) 15 (37.5) 24 (42.9) 0.752
No.8p (%) 22 (22.9) 9 (22.5) 13 (23.2) >0.999
No.7 (%) 7 (7.3) 3 (7.5) 4 (7.1) >0.999
No. 5 (%) 9 (9.4) 4 (10.0) 5 (8.9) >0.999
No. 6 (%) 6 (6.2) 4 (10.0) 2 (3.6) 0.392
No.13 (%) 46 (47.9) 19 (47.5) 27 (48.2) >0.999
No.17 (%) 38 (39.6) 16 (40.0) 22 (39.3) >0.999

EPNI, extrapancreatic perineural invasion; LN, lymph node; PLX1, extrapancreatic perineural invasion 1; PLX2, extrapancreatic perineural invasion 2.